Welcome to the DZIF -

the German Center for Infection Research

Research Areas

DZIF is doing research in nine areas:

Community-Acquired Infections at Mucosal Interfaces

Hepatitis

HIV

Infections of the Immunocompromised Host

Healthcare-Associated Infections

Malaria and Neglected Tropical Diseases

Emerging Infections

Novel Antibiotics

Tuberculosis

News

News and Press Releases:

Ein Schwarz-Weiß-Portraitbild von Prof. Dr. Michael P. Manns
© Karin Kaiser/MHH

The DZIF mourns the loss of Professor Michael P. Manns

A lab technician in a lab coat and cap pipettes liquids between rows of sample tubes in a sterile bench
© Forschungszentrum Borstel, Leibniz Lungenzentrum/C. Lange

Standard tests alone not sufficient to predict tuberculosis in immunocompromised individuals

While tuberculosis no longer plays a major role in large parts of Europe, many people still carry the pathogen. For people with weakened immune systems, for example after an organ transplant or in the
Photo of a group of people consisting of the scientists Dr. Christian Brandstetter and Prof. Till Strowig as well as the scientist Dr. Lisa Osbelt-Block in the middle.
© HZI/Janne Reinking

Fighting infections with the power of the microbiome

A balanced gut microbiome not only contributes to digestion, but is also an important protective factor against infections. Researchers at the Helmholtz Centre for Infection Research (HZI) led by Prof
DZIF scientist Prof. Dr. Dr. med. Susanne Herold
© JLU/Rolf K. Wegst

Susanne Herold admitted to the German National Academy of Sciences Leopoldina

Prof. Dr. Dr. med. Susanne Herold, a renowned lung and infection researcher at Justus Liebig University Giessen (JLU) and the University Hospital of Giessen and Marburg and scientist at the German
A close-up image of a healthcare professional wearing white gloves administering a vaccine injection into a person's upper arm using a syringe.
© Mufid Majnun auf Unsplash

Therapeutic vaccine for chronic hepatitis B enters first clinical trial in patients

TherVacB, a novel therapeutic vaccine for chronic hepatitis B developed under the leadership of Helmholtz Munich in collaboration with the German Center for Infection Research (DZIF), has entered its
All news

DZIF Prize for Translational Infection Research 2025

Apply now!

The DZIF Prize for Translational Infection Research honors special scientific contributions in the field of translational research. The prize is endowed with 5,000 euros. Applications can be submitted to the DZIF Academy until October 6, 2025.

More info
DZIF Prize for Translational Infection Research 2025
© hunthomas/Adobe Stock

Always up-to-date

Sign up for our quarterly newsletter and our press releases and stay up to date.

Select mailing lists
CAPTCHA
3 + 17 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Follow us on:

The DZIF Media Centre

The DZIF in Videos, Pictures and Print.

Find Media Content

Research in Focus

Hamburg - Lübeck - Borstel - Riems

Clinical Tuberculosis Center

The Clinical Tuberculosis Center provides the expertise and infrastructure for the optimization, prevention, diagnosis, and treatment of tuberculosis (TB) as well as for translating research results into clinical practice. The main objectives of the Clinical Tuberculosis Center include coordinating clinical research activities involving the DZIF TB cohort. This cohort includes [...]

Read more
Hannover - Braunschweig | Heidelberg | München | Tübingen

Transplant Cohort

Medical data and biological samples obtained from transplant patients are collected and managed across Germany with the help of the DZIF Transplant Cohort. The data and samples form the basis of scientific studies which investigate the connections between numerous factors influencing an organ’s susceptibility to infection and organ function. In [...]

Read more
Hannover - Braunschweig

Preclinical development of Amidochelocardins

The challenge of antibiotic drug development today is the discovery and optimisation of novel bioactive compounds that do not show cross-resistances with clinically applied antibiotics, ideally due to a novel mode of action (MoA) which adresses unexploited microbial targets. In the case of chelocardin, this antibiotic substance was identified several [...]

Read more
Tübingen

New strategies for specific eradication of Staphylococcus aureus

In this project, the scientists develop genetically engineered phage lysins and specific bacteriocins for the elimination of hospital germs such as Staphylococcus aureus, they clarify mechanisms of potential resistance mechanisms, and they analyse whether broad-spectrum or specifically acting agents have a more effective and lasting effect on colonization by [...]

Read more

Our Partner Sites

Location

Heidelberg

Research areas
Contact person
Stephan Urban

Prof. Dr. Stephan Urban

Heidelberg University
Deputy Coordinator Hepatitis
DZIF Professor "Translational Virology"
Partner Site Speaker Heidelberg
E-Mail Send mail
More about this location
Location

Hamburg - Lübeck - Borstel - Riems

Research areas
Contact person
More about this location
Location

Bonn - Köln

Research areas
Contact person
Prof Achim Hörauf: Coordinator of the consortium "Neglected tropical diseases" at DZIF.

Prof. Dr. Achim Hörauf

University Hospital Bonn
Deputy Partner Site Speaker Bonn-Köln
Deputy Coordinator Malaria and Neglected Tropical Diseases
E-Mail Send mail
Ullrich Bethe

Dr. Ullrich Bethe

University Hospital Cologne
Project Manager Clinical Trial Office (CTO)
Interim Partner Site Manager Cologne
E-Mail Send mail
More about this location
Location

Hannover - Braunschweig

Research areas
Contact person
Silke Hartmann

Dr. Silke Hartmann

Hannover Medical School
Partner Site Manager Hannover - Braunschweig
Project Manager Community-Acquired Infections at Mucosal Interfaces
E-Mail Send mail
More about this location
München Tübingen Heidelberg Giessen – Marburg – Langen Bonn – Köln Hannover – Braunschweig Hamburg – Lübeck Borstel – Riems
15
Databases- & Biobanks 2023